User: TahirAmin Topic: IP
Category: patent-legal-regime :: india
Last updated: Sep 30 2014 18:03 IST RSS 2.0
 
1 to 20 of 2,606    
Modi must resist U.S. pressure on drug patents - MSF 30.9.2014 Sify Finance
Also found in: [+]
Modi visit fuels WTO solution hope 29.9.2014 Telegraph: Business
New Delhi, Sept. 28: The meeting between US President Barack Obama and Indian Prime Minister Narendra Modi this week will be keenly watched to see whether the two countries are able to break the ice on the food security issue, paving the way for the implementation of the trade facilitation agreement.
Also found in: [+]
Modi asked to resist US pressure on IP and pharma sector 26.9.2014 CNN-IBN: Business
An international medical agency on Friday asked Prime Minister Narendra Modi to resist US pressure to drop the use of public health safeguards in its intellectual property laws, which it said has enabled India to become the 'pharmacy of the developing world'.
Also found in: [+]
Modi asked to resist US pressure on IP and pharma sector 26.9.2014 deccanherald.com
An international medical agency today asked Prime Minister Narendra Modi to resist US pressure to drop the use of public health safeguards in its intellectual property laws, which it said has enabled India to become the pharmacy of the developing world. "Indias production of affordable medicines is a vital life-line for MSFs medical humanitarian operations and millions of people in developing countries," said Rohit Malpani, director of Policy and Analysis for Medecins Sans Frontieres (Doctors Without Borders) Access Campaign. "Indias patent laws and policies have fostered robust generic competition over the past decade, which has brought the price of medicines down substantially - in the case of HIV, by more than 90 per cent. The world cant afford to see Indias pharmacy shut down by US commercial interests," he said. India supplies affordable generic medicines to people and governments worldwide, including to MSF's medical humanitarian projects, which are present in more than 60 countries, MSF said in a ...
Also found in: [+]
Intellectual property rights issues could get a resolution system 25.9.2014 All Economy & Policy Stories
One of the main outcomes of Prime Minister Narendra Modi's visit to the US is going to be launch of a dialogue mechanism on issues related to the intellectual property rights (IPR), an aspect that has been a major irritant in India-US bilateral ...
Also found in: [+]
Will Modi bow to US pressure to modify India’s pro-people patent law? 23.9.2014 TOI: India
A large number of civil society groups and public intellectuals have issued a public statement expressing concern over the government’s decision to review India’s positions on intellectual property ...
Also found in: [+]
Modi urged not to amend Patents Act under US pressure 23.9.2014 All News-IANS Stories
Saying that much pressure will be put on Prime Minister Narendra Modi during his US visit to modify India's Patents Act, a group of concerned citizens and groups Tuesday asked the government to desist from plans to make amendments to increase patent ...
Also found in: [+]
Modi urged not to amend Patents Act under US pressure 23.9.2014 New Kerala: India News
New Delhi, Sep 23 : Saying that much pressure will be put on Prime Minister Narendra Modi during his US visit to modify India's Patents Act, a group of concerned citizens and groups Tuesday asked the government to desist from plans to make amendments to increase patent protection.
Also found in: [+]
PM Narendra Modi urged not to amend Patents Act under US pressure 23.9.2014 Oneindia.in: News
New Delhi, Sep 23: Saying that much pressure will be put on Prime Minister Narendra Modi during his US visit to modify India's Patents Act, a group of concerned citizens and groups Tuesday asked the government to desist from plans to
Also found in: [+]
IPR and India's competitiveness (Column: Active Voice) 22.9.2014 All News-IANS Stories
Intellectual Property Rights are important from the standpoint of maintaining present as well as ensuring future competitiveness. They also have an impact on the FDI inflows in a developing country, which helps not just in terms of capital inflows, ...
Also found in: [+]
Intellectual Property Rights and India's competitiveness 22.9.2014 ET: Policy
According to the most recent IP Index by GIPC of the US Chamber of Commerce, India's rank is the last among 25 countries for which the Center prepares the Index.
Also found in: [+]
IPR and India's competitiveness 22.9.2014 New Kerala: India News
By Amit Kapoor : Intellectual Property Rights are important from the standpoint of maintaining present as well as ensuring future competitiveness. They also have an impact on the FDI inflows in a developing country, which helps not just in terms of capital inflows, but also in terms of technology and expertise. Strengthening IPR thus becomes imperative from the viewpoint of economic development.
Also found in: [+]
IPR and India's competitiveness (Column: Active Voice) 22.9.2014 Sify Finance
. They also have an impact on the FDI inflows in a developing country, which helps not just in terms of capital inflows, but also in terms of technology and expertise. Strengthening IPR thus becomes imperative from the viewpoint of economic development. According to the most recent IP Index by GIPC (Global Intellectual Property Center) of the US Chamber of Commerce, India's rank is the last among 25 countries for which the Center prepares the Index. It is alarming, and steps need to be taken to ensure we do better on various aspects covered under the specific index.
Also found in: [+]
Irritants on Modi itinerary 21.9.2014 Telegraph: Business
New Delhi, Sept. 21: Prime Minister Narendra Modi's trip to the US later this week will give the Obama administration an opportunity to not only woo an important ally in Asia but also take up issues ranging from India's pharma patent regime to its stand at the World Trade Organization.
Also found in: [+]
Patent And The Price 21.9.2014 Kangla Online
Patent And The Price
Also found in: [+]
‘PM Modi must firmly rebuff US pressure to dilute India’s robust patent law’ 19.9.2014 HBL: Features
Concessions will disarm India in its pursuit of the right to health
Also found in: [+]
We need an ecosystem of innovation to retain our young scientists: Novartis India chief 19.9.2014 HBL: Companies
MNCs overseas hire 15% of their research hands from India
Also found in: [+]
Hepatitis C drug in India to cost 49 lakh less than in US 16.9.2014 ET: Pharma
The voluntary licencing deal promises to make the drug cheap in India as well as up to 91 countries where the Indian firms are allowed to sell it.
Also found in: [+]
Pill for thought: Sweetheart deals that hurt consumers 16.9.2014 Rediff: Top Stories (India)
'Pay-for-delay' settlements between drug patent-holders and generics manufacturers to delay the launch of cheaper generic medicine are increasingly being scrutinised by antitrust regulators
Also found in: [+]
Hepatitis C drug in India to cost 49 lakh less than in US 16.9.2014 TOI: India
Sofosbuvir, the wonder medicine for Hepatitis C that costs $84,000 or Rs 50.4 lakh for a 24-week treatment regimen in the US, will soon be available in India for about $1,800 or roughly Rs 1.1 lakh for the same ...
Also found in: [+]
1 to 20 of 2,606